Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

13 trials with published results (5%)

Research Maturity

110 completed trials (46% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.3%

3 terminated out of 238 trials

Success Rate

97.3%

+10.8% vs benchmark

Late-Stage Pipeline

13%

31 trials in Phase 3/4

Results Transparency

12%

13 of 110 completed with results

Key Signals

13 with results97% success

Data Visualizations

Phase Distribution

140Total
Not Applicable (70)
Early P 1 (1)
P 1 (21)
P 2 (17)
P 3 (11)
P 4 (20)

Trial Status

Completed110
Recruiting53
Unknown37
Not Yet Recruiting15
Active Not Recruiting10
Enrolling By Invitation7

Trial Success Rate

97.3%

Benchmark: 86.6%

Based on 110 completed trials

Clinical Trials (238)

Showing 20 of 20 trials
NCT07220915Phase 3Recruiting

Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections

NCT00967785Phase 1Completed

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NCT00006150RecruitingPrimary

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

NCT06637904Not ApplicableCompleted

TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections

NCT02505386Phase 4CompletedPrimary

Pharmacokinetics of Ertapenem in Patients Aged Over 75

NCT05875961Phase 1Completed

Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults

NCT05603728Recruiting

Exactech Shoulder Post Market Clinical Follow-up Study

NCT05797246Phase 2Active Not Recruiting

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT07189858Not ApplicableCompleted

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada

NCT06702878Phase 3Completed

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

NCT06911658Completed

Infectious Complications After Esophagectomy

NCT05699174Phase 3RecruitingPrimary

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

NCT05947955Phase 2Recruiting

Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

NCT07796945CompletedPrimary

Human Neutrophil Lipocalin as an Aid in the Diagnosis of Bacterial Infection in the Emergency Department

NCT07215871Phase 1Enrolling By Invitation

Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

NCT06592586Phase 2Active Not Recruiting

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

NCT05459155Not ApplicableCompletedPrimary

Effect of Synapse Medicine Decision Support on Inpatient Pharmacist Efficacy and Efficiency

NCT05568966Recruiting

Collection of Blood Samples for New Diagnostic Devices 2

NCT06950892Recruiting

Remote Sputum Collection in Cystic Fibrosis

NCT07607470Recruiting

Large Algorithm Setting and Validation Study

Scroll to load more

Research Network

Activity Timeline